ONE CAVENDISH PLACE, LONDON, X0
Director Departure - Dr. Annalisa Jenkins Not Standing for Re-Election
Reports Full Year 2025 Financial Results and Provides Corporate Highlights
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Investor Presentation
Reg. FD, Other Events
Financial Results, Press Release
Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights
Other Events
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
PRE 14A
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership